Acute Respiratory Distress Syndrome Market

According to Renub Research’s latest report “Acute Respiratory Distress Syndrome Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” Acute

Respiratory Distress Syndrome Market is estimated to reach US$ 1.83 Billion by 2028. Acute respiratory distress syndrome (ARDS) (chest X-ray) is a lifethreatening condition of seriously ill patients, identified by poor oxygenation, pulmonary infiltrates, and acuity of onset. Sepsis syndrome with multiple organ failure remains the most common cause of death while respiratory failure causes a less percentage of deaths. Sepsis began in response to an infection. When sepsis is not recognized early and managed promptly, it can lead to septic shock, multiple organ failure, and, death.